(en) Shrikanta Chattopadhyay, Richard G. Moran et I. David Goldman, « Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications », Molecular Cancer Therapeutics, vol. 6, , p. 404-417 (ISSN1535-7163 et 1538-8514, PMID17308042, DOI10.1158/1535-7163.MCT-06-0343, lire en ligne, consulté le )
(en) Shrikanta Chattopadhyay, Richard G. Moran et I. David Goldman, « Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications », Molecular Cancer Therapeutics, vol. 6, , p. 404-417 (ISSN1535-7163 et 1538-8514, PMID17308042, DOI10.1158/1535-7163.MCT-06-0343, lire en ligne, consulté le )
Charles J. Barnett, Thomas M. Wilson et Michael E. Kobierski, « A Practical Synthesis of Multitargeted Antifolate LY231514 », Organic Process Research & Development, vol. 3, , p. 184-188 (ISSN1083-6160, DOI10.1021/op9802172, lire en ligne, consulté le )
(en) Kumar Prabhash, « High Plasma Exposure to Pemetrexed Leads to Severe Hyponatremia in Patients With Advanced Non Small Cell Lung Cancer Receiving Pemetrexed-Platinum Doublet Chemotherapy - PubMed », Cancer management and research, vol. 6, , p. 261–265 (ISSN1179-1322, PMID24940080, DOI10.2147/CMAR.S60177, lire en ligne, consulté le ).
E. C. Taylor, P. J. Harrington, S. R. Fletcher et G. P. Beardsley, « Synthesis of the antileukemic agents 5,10-dideazaaminopterin and 5,10-dideaza-5,6,7,8-tetrahydroaminopterin », Journal of Medicinal Chemistry, vol. 28, , p. 914-921 (ISSN0022-2623, PMID4009615, lire en ligne, consulté le )
(en) R. G. Moran, S. W. Baldwin, E. C. Taylor et C. Shih, « The 6S- and 6R-diastereomers of 5, 10-dideaza-5, 6, 7, 8-tetrahydrofolate are equiactive inhibitors of de novo purine synthesis. », Journal of Biological Chemistry, vol. 264, 12/15/1989, p. 21047-21051 (ISSN0021-9258 et 1083-351X, PMID2592365, lire en ligne, consulté le )
(en) Shrikanta Chattopadhyay, Richard G. Moran et I. David Goldman, « Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications », Molecular Cancer Therapeutics, vol. 6, , p. 404-417 (ISSN1535-7163 et 1538-8514, PMID17308042, DOI10.1158/1535-7163.MCT-06-0343, lire en ligne, consulté le )
Charles J. Barnett, Thomas M. Wilson et Michael E. Kobierski, « A Practical Synthesis of Multitargeted Antifolate LY231514 », Organic Process Research & Development, vol. 3, , p. 184-188 (ISSN1083-6160, DOI10.1021/op9802172, lire en ligne, consulté le )
(ja) Michihiro Shino, « [Effectiveness of Steroids for the Rash Side Effect of Pemetrexed] - PubMed », Gan to kagaku ryoho. Cancer & chemotherapy, vol. 40, no 1, , p. 75–78 (ISSN0385-0684, PMID23306922, lire en ligne, consulté le ).
(en) Kumar Prabhash, « High Plasma Exposure to Pemetrexed Leads to Severe Hyponatremia in Patients With Advanced Non Small Cell Lung Cancer Receiving Pemetrexed-Platinum Doublet Chemotherapy - PubMed », Cancer management and research, vol. 6, , p. 261–265 (ISSN1179-1322, PMID24940080, DOI10.2147/CMAR.S60177, lire en ligne, consulté le ).
(en) R. G. Moran, S. W. Baldwin, E. C. Taylor et C. Shih, « The 6S- and 6R-diastereomers of 5, 10-dideaza-5, 6, 7, 8-tetrahydrofolate are equiactive inhibitors of de novo purine synthesis. », Journal of Biological Chemistry, vol. 264, 12/15/1989, p. 21047-21051 (ISSN0021-9258 et 1083-351X, PMID2592365, lire en ligne, consulté le )
nih.gov
ncbi.nlm.nih.gov
E. C. Taylor, P. J. Harrington, S. R. Fletcher et G. P. Beardsley, « Synthesis of the antileukemic agents 5,10-dideazaaminopterin and 5,10-dideaza-5,6,7,8-tetrahydroaminopterin », Journal of Medicinal Chemistry, vol. 28, , p. 914-921 (ISSN0022-2623, PMID4009615, lire en ligne, consulté le )
(en) R. G. Moran, S. W. Baldwin, E. C. Taylor et C. Shih, « The 6S- and 6R-diastereomers of 5, 10-dideaza-5, 6, 7, 8-tetrahydrofolate are equiactive inhibitors of de novo purine synthesis. », Journal of Biological Chemistry, vol. 264, 12/15/1989, p. 21047-21051 (ISSN0021-9258 et 1083-351X, PMID2592365, lire en ligne, consulté le )
(en) Shrikanta Chattopadhyay, Richard G. Moran et I. David Goldman, « Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications », Molecular Cancer Therapeutics, vol. 6, , p. 404-417 (ISSN1535-7163 et 1538-8514, PMID17308042, DOI10.1158/1535-7163.MCT-06-0343, lire en ligne, consulté le )
(ja) Michihiro Shino, « [Effectiveness of Steroids for the Rash Side Effect of Pemetrexed] - PubMed », Gan to kagaku ryoho. Cancer & chemotherapy, vol. 40, no 1, , p. 75–78 (ISSN0385-0684, PMID23306922, lire en ligne, consulté le ).
(en) Kumar Prabhash, « High Plasma Exposure to Pemetrexed Leads to Severe Hyponatremia in Patients With Advanced Non Small Cell Lung Cancer Receiving Pemetrexed-Platinum Doublet Chemotherapy - PubMed », Cancer management and research, vol. 6, , p. 261–265 (ISSN1179-1322, PMID24940080, DOI10.2147/CMAR.S60177, lire en ligne, consulté le ).